Keros Therapeutics (KROS) Shares Issued (2019 - 2025)
Historic Shares Issued for Keros Therapeutics (KROS) over the last 7 years, with Q3 2025 value amounting to $117000.0.
- Keros Therapeutics' Shares Issued fell 8839.29% to $117000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 7540.0%. This contributed to the annual value of $12.1 million for FY2024, which is 27646.51% up from last year.
- Latest data reveals that Keros Therapeutics reported Shares Issued of $117000.0 as of Q3 2025, which was down 8839.29% from $17000.0 recorded in Q2 2025.
- Keros Therapeutics' 5-year Shares Issued high stood at $107.3 million for Q1 2023, and its period low was -$105.2 million during Q2 2023.
- Moreover, its 5-year median value for Shares Issued was $245000.0 (2021), whereas its average is $879000.0.
- Examining YoY changes over the last 5 years, Keros Therapeutics' Shares Issued showed a top increase of 13843428.57% in 2022 and a maximum decrease of 2351183.67% in 2022.
- Over the past 5 years, Keros Therapeutics' Shares Issued (Quarter) stood at $245000.0 in 2021, then crashed by 23511.84% to -$57.4 million in 2022, then surged by 101.4% to $804000.0 in 2023, then surged by 204.1% to $2.4 million in 2024, then plummeted by 95.21% to $117000.0 in 2025.
- Its Shares Issued was $117000.0 in Q3 2025, compared to $17000.0 in Q2 2025 and $4000.0 in Q1 2025.